CommercialAdministrativeLow impact
07.05.07e, Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic Malignancies
Independence Blue Cross·Gastroenterology, Oncology, Radiology·Pharmacy
Effective date
Oct 29, 2025
We identified it
Jun 19, 2026
Summary
A commercial policy regarding drug-eluting beads and bland embolization for hepatic malignancies treatment has been reissued with an effective date of October 29, 2025. This appears to be a policy reissuance rather than substantive changes, but the content details are not provided in the summary.
Action Required
By October 29, 2025: Billing team should review the full policy document at the provided URL to determine if any changes affect hepatic malignancy treatment billing procedures. Monitor for any updates to prior authorization requirements or coverage criteria for drug-eluting bead procedures.